LATS2 and ovarian carcinoma: Several interesting findings emerged from this study: Firstly, the analysis of 15 databases indicated that neither LATS1 nor LATS2 expression was associated with favorable survival in ovarian cancer and that LATS2 may even have a negative role for survival.